Tricell Biologics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.77 Cr
- Satisfied Charges ₹ 4.00 M
- Revenue Growth -57.26%
- Profit Growth -104.16%
- Ebitda -60.90%
- Net Worth -6.02%
- Total Assets 5.22%
About Tricell Biologics
Tricell Biologics Private Limited (TBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 February 2017 (Seven years and 11 months 21 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.77 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sheik Salahudeen and Vellore Surendranath serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TN2017PTC114837
- Company No.
114837
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Tricell Biologics Private Limited offer?
Tricell Biologics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Infusion Syringes & Supplies, Blood Collection Tubes, Salon, Spa Kits & Equipments, Salon Equipment, Body Tattoo Accessories, Surgical & ICU Equipments, Electromedical Equipment, Optical, Laser Instruments & Devices.
Who are the key members and board of directors at Tricell Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheik Salahudeen  | Director | 08-Feb-2017 | Current |
| Vellore Surendranath | Director | 08-Feb-2017 | Current |
Financial Performance of Tricell Biologics.
Tricell Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.26% decrease. The company also saw a substantial fall in profitability, with a 104.16% decrease in profit. The company's net worth dipped by a decrease of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tricell Biologics?
Unlock access to Tricell Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cms Healthcare LlpSheik Salahudeen is a mutual person
- Ossistec Medi Equipments Llp
Vellore Surendranath is a mutual person
- Vcsmed India Private Limited
Vellore Surendranath is a mutual person
Charges (Loans)
₹47.67 M
₹4.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.97 Cr
- Canara Bank : 0.79 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2022 | Canara Bank | ₹7.93 M | Open |
| 31 Jul 2018 | Hdfc Bank Limited | ₹3.97 Cr | Open |
| 12 Jan 2018 | Canara Bank | ₹4.00 M | Satisfied |
How Many Employees Work at Tricell Biologics?
Unlock and access historical data on people associated with Tricell Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tricell Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tricell Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.